| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Brompheniramine maleate |
Is a |
False |
Brompheniramine (substance) |
Inferred relationship |
Some |
|
| Brompheniramine measurement |
Component |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
1 |
| Brompheniramine adverse reaction |
Causative agent (attribute) |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
1 |
| Allergy to brompheniramine |
Causative agent (attribute) |
False |
Brompheniramine (substance) |
Inferred relationship |
Some |
|
| Brompheniramine maleate 2mg/5mL elixir |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brompheniramine (substance) |
Inferred relationship |
Some |
|
| Brompheniramine maleate 10mg/1mL injection 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brompheniramine (substance) |
Inferred relationship |
Some |
|
| Product containing brompheniramine maleate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brompheniramine (substance) |
Inferred relationship |
Some |
|
| Brompheniramine maleate+codeine phosphate+phenylpropanolamine hydrochloride 2mg/5mL 10mg/5mL 12.5mg/5mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brompheniramine (substance) |
Inferred relationship |
Some |
|
| Brompheniramine maleate+dextromethorphan hydrobromide+phenylpropanolamine hydrochloride 2mg/5mL 10mg/5mL 12.5mg/5mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brompheniramine (substance) |
Inferred relationship |
Some |
|
| Brompheniramine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 2mg/5mL 10mg/5mL 30mg/5mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brompheniramine (substance) |
Inferred relationship |
Some |
|
| Brompheniramine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 4mg/5mL 15mg/5mL 60mg/5mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brompheniramine (substance) |
Inferred relationship |
Some |
|
| Brompheniramine maleate 10mg/mL injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brompheniramine (substance) |
Inferred relationship |
Some |
|
| Brompheniramine maleate 6 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brompheniramine (substance) |
Inferred relationship |
Some |
|
| Brompheniramine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 4mg/5mL 15mg/5mL 45mg/5mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brompheniramine (substance) |
Inferred relationship |
Some |
|
| Brompheniramine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 4mg/5mL 30mg/5mL 60mg/5mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brompheniramine (substance) |
Inferred relationship |
Some |
|
| Product containing brompheniramine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
1 |
| Brompheniramine maleate + dextromethorphan hydrobromide + phenylpropanolamine hydrochloride 2mg/10mg/12.5mg liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brompheniramine (substance) |
Inferred relationship |
Some |
|
| Brompheniramine maleate + guaifenesin + hydrocodone bitartrate 2mg/200mg/5mg syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brompheniramine (substance) |
Inferred relationship |
Some |
|
| Brompheniramine maleate + hydrocodone bitartrate + pseudoephedrine hydrochloride 2mg/1.7mg/30mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brompheniramine (substance) |
Inferred relationship |
Some |
|
| Product containing precisely brompheniramine 12 milligram and pseudoephedrine hydrochloride 120 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brompheniramine (substance) |
Inferred relationship |
Some |
|
| Product containing precisely brompheniramine 6 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brompheniramine (substance) |
Inferred relationship |
Some |
|
| Brompheniramine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brompheniramine (substance) |
Inferred relationship |
Some |
|
| Brompheniramine maleate + hydrocodone bitartrate + pseudoephedrine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brompheniramine (substance) |
Inferred relationship |
Some |
|
| Brompheniramine maleate + pseudoephedrine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brompheniramine (substance) |
Inferred relationship |
Some |
|
| Brompheniramine maleate + pseudoephedrine hydrochloride 16mg/240mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brompheniramine (substance) |
Inferred relationship |
Some |
|
| Brompheniramine maleate + pseudoephedrine hydrochloride 16mg/240mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brompheniramine (substance) |
Inferred relationship |
Some |
|
| Product containing precisely brompheniramine 12 milligram and pseudoephedrine hydrochloride 120 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brompheniramine (substance) |
Inferred relationship |
Some |
|
| Product containing precisely brompheniramine 6 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brompheniramine (substance) |
Inferred relationship |
Some |
|
| Product containing brompheniramine and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
1 |
| Allergy to brompheniramine |
Causative agent (attribute) |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely brompheniramine 12 milligram and pseudoephedrine hydrochloride 120 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely brompheniramine 6 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Brompheniramine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely brompheniramine 12 milligram and pseudoephedrine hydrochloride 120 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brompheniramine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely brompheniramine 12 milligram and pseudoephedrine hydrochloride 120 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Brompheniramine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely brompheniramine 6 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brompheniramine (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely brompheniramine 6 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
2 |
| Brompheniramine maleate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
|
| Product containing precisely brompheniramine 12 milligram and pseudoephedrine hydrochloride 120 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely brompheniramine 6 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Brompheniramine (substance) |
Inferred relationship |
Some |
1 |
| Brompheniramine- and pseudoephedrine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
1 |
| Brompheniramine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
1 |
| Product containing brompheniramine and guaifenesin and hydrocodone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
2 |
| Product containing brompheniramine and guaifenesin and hydrocodone in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
2 |
| Brompheniramine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
1 |
| Product containing only brompheniramine and guaifenesin and hydrocodone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
2 |
| Brompheniramine and pseudoephedrine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
1 |
| Brompheniramine and guaifenesin and hydrocodone only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
2 |
| Brompheniramine and pseudoephedrine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
1 |
| Product containing only brompheniramine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
1 |
| Brompheniramine 800 microgram/mL and dextromethorphan 3 mg/mL and pseudoephedrine 12 mg/mL oral solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
1 |
| Brompheniramine 800 microgram/mL and dextromethorphan 3 mg/mL and pseudoephedrine 12 mg/mL oral solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
1 |
| Brompheniramine 800 microgram/mL and dextromethorphan 6 mg/mL and pseudoephedrine 12 mg/mL oral solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
1 |
| Brompheniramine 800 microgram/mL and dextromethorphan 6 mg/mL and pseudoephedrine 12 mg/mL oral solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
1 |
| Brompheniramine and codeine and phenylpropanolamine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
1 |
| Product containing only brompheniramine and dextromethorphan and phenylpropanolamine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
1 |
| Brompheniramine- and codeine- and phenylpropanolamine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
1 |
| Product containing brompheniramine and codeine and phenylpropanolamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
1 |
| Brompheniramine- and dextromethorphan- and phenylpropanolamine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
1 |
| Brompheniramine- and dextromethorphan- and pseudoephedrine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
1 |
| Product containing only brompheniramine in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
1 |
| Product containing only brompheniramine and dextromethorphan and phenylpropanolamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
1 |
| Product containing only brompheniramine and dextromethorphan and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
1 |
| Product containing only brompheniramine and dextromethorphan and pseudoephedrine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
1 |
| Brompheniramine- and dextromethorphan- and pseudoephedrine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
1 |
| Product containing brompheniramine in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
1 |
| Product containing brompheniramine and dextromethorphan and phenylpropanolamine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
1 |
| Product containing only brompheniramine and codeine and phenylpropanolamine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely brompheniramine 6 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
2 |
| Brompheniramine- and caffeine- and paracetamol-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
2 |
| Brompheniramine and caffeine and paracetamol only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
2 |
| Product containing only brompheniramine and caffeine and paracetamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
2 |
| Product containing brompheniramine and caffeine and paracetamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
2 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]